Piershale Financial Group’s abrdn Life Sciences Investors HQL Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2023
Q2
$11.4K Buy
839
+19
+2% +$257 0.01% 105
2023
Q1
$11.4K Buy
820
+20
+3% +$278 0.01% 104
2022
Q4
$11.4K Buy
+800
New +$11.4K 0.01% 105